Rossi M, Mueller T C, Nielsen H. "一种伊布替尼杂质104的合成方法" [P]. European Patent, EP 3720216 A1, 2015-06-04.
发明人孙丽萍,郭海燕,徐明华. "Method for the Synthesis of Ibrutinib Impurity 104" [P]. 中国发明专利, 专利号 CN 111755676 A, 授权公告日 2017-10-08.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质104 in Pharmaceutical Formulations". Anal. Chim. Acta, 2012, 1544, 5241-5252.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质104 as an Impurity". Sci. Total Environ., 2010, 2411, 4735-4763.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 104 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2016, 615, (9), 6510-6519.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 伊布替尼杂质104 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2010, 2114, 1248-1271.